About Velsera
Velsera is a company based in Boston (United States) founded in 2022. Velsera has completed 1 acquisition, including PierianDx. Velsera offers products and services including Seven Bridges, GRAF, ARIA, Clinical Genomics Workspace, and Knowledgebase. Velsera operates in a competitive market with competitors including Helix, Benchling, BioAge Labs, Ingenuity Systems and Cellworks, among others.
- Headquarter Boston, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Velsera
Velsera offers a comprehensive portfolio of products and services, including Seven Bridges, GRAF, ARIA, Clinical Genomics Workspace, and Knowledgebase.
Platform for bioinformatic analysis and pipeline development in research.
Tool for advanced reference genome analysis and variant detection.
Platform for secure data harmonization and sharing in health tech.
Tool for clinical NGS reporting and decision support in diagnostics.
Database for IVD-grade variant analysis in precision medicine.
People of Velsera
Unlock access to complete
Software Development Team
26 people
Senior Team
10 people
Product Management Team
9 people
Leadership Team
8 people
Bioinformatics Team
4 people
Finance and Accounting
4 people
Human Resources and Administration
4 people
Clinical Team
3 people
Unlock access to complete
Funding Insights of Velsera
Detailed funding history for Velsera
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Velsera
Velsera has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include PierianDx.
Investment portfolio details for Velsera
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Genetic tests for individualized disease diagnosis are provided.
|
Locked | Locked | 2014 | Locked |
Complete acquisition details for Velsera
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Velsera
Detailed financials for Velsera
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Velsera Comparisons
Peer comparison for Velsera
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Velsera
Velsera operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helix, Benchling, BioAge Labs, Ingenuity Systems and Cellworks, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genomic database for clinical research is provided.
|
|
| Locked | Locked | Locked |
Cloud-based bioinformatics platform is offered for biotech research.
|
|
| Locked | Locked | Locked |
Bioinformatics platform is provided for biomarkers and drug discovery.
|
|
| Locked | Locked | Locked |
Genomic data is analyzed and interpreted via web-based applications.
|
|
| Locked | Locked | Locked |
Biosimulation platform developed for therapeutic design in life sciences.
|
|
| Locked | Locked | Locked |
AI-based omics data analysis solutions are provided to researchers.
|
Detailed competitors of Velsera
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Velsera
Complete news archive for Velsera
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Velsera
Velsera was founded in 2022.
Velsera is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Gavin Nichols is the current CEO of Velsera.
Velsera was founded in 2022 in Boston, United States, within the biotechnology sector. Software is developed by the company to support omic data analysis, including features for annotation, reporting, sample processing, and workflow automation. Assistance is provided for disease diagnosis through these tools, which are utilized by researchers in genomic and related fields. Operations focus on enhancing data handling efficiency in research environments.
Velsera's top competitors include Helix, Benchling and BioAge Labs.
Velsera offers Seven Bridges, GRAF, ARIA, Clinical Genomics Workspace, and Knowledgebase.
Velsera has made 1 acquisition, including PierianDx.